Timothy Gray - 20 May 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Reporting relationship: Chief Financial Officer
Issuer ticker: ATEX
Reported as of: 20 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 15:21:05 UTC
Prior SEC filing: 20 May 2025
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Timothy Gray filed Form 4 for Anterix Inc. (ATEX) on 22 May 2025.

Key facts

This page summarizes Timothy Gray's Form 4 filing for Anterix Inc. (ATEX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 May 2025, 15:21.

Change

Previous filing in this sequence was filed on 20 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001629762 Primary reporting owner

Gray Timothy

Relationship: Chief Financial Officer
Address: 3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK
Signature: s/ Gena L. Ashe, Attorney-in-Fact
Signature date: 22 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATEX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +53,491
Change %
Price: $0.000000
Shares after: 53,491
Date: 20 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 53,491
Exercise price: $34.96
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.